ArticleCognitive neurodynamics2021
Morphological analysis of subcortical structures for assessment of cognitive dysfunction in Parkinson's disease using multi-atlas based segmentation.
Article in Cognitive neurodynamics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 10 citations in OpenAlex.
- Diffusion-Informed Joint Segmentation Enhances Detection of Thalamic Atrophy in Parkinson's Disease.Brain topography · 2026Article
- Amygdala subregion MRI alterations in Parkinson's disease correlate with olfactory function.Frontiers in aging neuroscience · 2026Article
- Selective amygdala subregional atrophy in Parkinson's disease: from subjective cognitive decline to mild cognitive impairment.Frontiers in aging neuroscience · 2026Article
- Cerebellar MRI-based radiomics models for identifying mild cognitive impairment: a retrospective multicenter study in Southeast China.Frontiers in aging neuroscience · 2025Article
- A worldwide study of subcortical shape as a marker for clinical staging in Parkinson's disease.NPJ Parkinson's disease · 2024Article
- Analysis of cognitive dysfunction in Parkinson's disease using voxel based morphometry and radiomics.Cognitive processing · 2024Article
- Mild cognitive impairment in Parkinson's disease: current view.Frontiers in cognition · 2024Review
- Pathobiology of Cognitive Impairment in Parkinson Disease: Challenges and Outlooks.International journal of molecular sciences · 2023Review
- Morphological changes in Parkinson's disease based on magnetic resonance imaging: A mini-review of subcortical structures segmentation and shape analysis.World journal of psychiatry · 2022Review
- EEG-FCV: An EEG-Based Functional Connectivity Visualization Framework for Cognitive State Evaluation.Frontiers in psychiatry · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cognitive impairment in Parkinson's Disease (PD) is the most prevalent non-motor symptom that requires analysis of anatomical associations to cognitive decline in PD. The objective of this study is to analyse the morphological variations of the subcortical structures to assess cognitive dysfunction in PD. In this study, T1 MR images of 58 Healthy Control (HC) and 135 PD subjects categorised as 91 Cognitively normal PD (NC-PD), 25 PD with Mild Cognitive Impairment (PD-MCI) and 19 PD with Dementia (PD-D) subjects, based on cognitive scores are utilised. The 132 anatomical regions are segmented using spatially localized multi-atlas model and volumetric analysis is carried out. The morphological alterations through textural features are captured to differentiate among the HC and PD subjects under different cognitive domains. The volumetric differences in the segmented subcortical structures of accumbens, amygdala, caudate, putamen and thalamus are able to predict cognitive impairment in PD. The volumetric distribution of the subcortical structures in PD-MCI subjects exhibit an overlap with the HC group due to lack of spatial specificity in their atrophy levels. The 3D GLCM features extracted from the significant subcortical structures could discriminate HC, NC-PD, PD-MCI and PD-D subjects with better classification accuracies. The disease related atrophy levels of the subcortical structures captured through morphological analysis provide sensitive evaluation of cognitive impairment in PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.